Therapeutic Nuclear Medicine Market- Industry Analysis and forecast 2019 – 2027

[mayuri kathade]

Therapeutic Nuclear Medicine Market size was valued US$ X.1 Bn. in 2019 and the total revenue is expected to grow at CAGR 4.7% from 2019 to 2027, reaching nearly US$ XX Bn.

To know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID 19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Nuclear medicines or radiopharmaceuticals are regular medications that are utilized for the diagnosis of dysfunctions in human body tissue. Nuclear medicines are utilized for both diagnostic and remedial purposes and there are 30+ explicit radiopharmaceuticals utilized by medical specialists. Different types of nuclear medicines are valuable in treating cancer, neurological issues, gastrointestinal, and different diseases.

Growing rate of disease is one of the main factors expected to boost the market for nuclear medicine. For example, as indicated by WHO, in 2019, around the world there were an expected 9.6 million deaths because of cancer. Moreover, the expanding prevalence of cardiovascular diseases is adding to the growth of the nuclear medicine market.

Cancer causes nearly one out of six deaths over the world and the population experiencing different type of it is expanding continuously because of lifestyle changes involving tobacco and liquor, low intake of leafy foods, and absence of physical activity.
Advances in radiotracers, approach of alpha radio immunotherapy based focused on cancer treatments, and ventures by means of public and private partnerships to change symptomatic measures are some of different components expected to drive the interest in radiopharmaceuticals near future. On the other hand, significantly shorter half-existence of radiopharmaceuticals, generously significant expense of these specific medicines are some of the restraints impeding the market from achieving more prominent benefit.

North America dominated the general market as far as income in 2019 because of high interests in R&D and backing of government towards the utilization of medical isotopes which are driving the market. Likewise, the large share can be ascribed to the advancement of novel technologies for radioisotope production, government funding, and company initiatives in the region. The Europe market additionally held a large share in the global market in 2019.

The market in Asia Pacific is projected to grow significantly during the forecast period. Rising geriatric population and awareness about nuclear medicines and molecular imaging are adding to the growth of the radiopharmaceuticals market in this region. Besides, this region is focusing in on the improvement of radiopharmaceuticals for the diagnosis and treatment of different diseases.

The objective of the report is to present a comprehensive analysis of the Therapeutic Nuclear Medicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Therapeutic Nuclear Medicine Market dynamics, structure by analyzing the market segments and projects the Therapeutic Nuclear Medicine Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Therapeutic Nuclear Medicine Market make the report investor’s guide.
Scope of the Therapeutic Nuclear Medicine Market: Inquire before buying

Therapeutic Nuclear Medicine Market, By Type

• Diagnostic Nuclear Medicine
• Therapeutic Nuclear Medicine
• Brachytherapy Isotopes
Therapeutic Nuclear Medicine Market, By Application

• SPECT Applications
• PET Applications
• Therapeutic Applications
Therapeutic Nuclear Medicine Market, By Procedural Volume Assessment

• Diagnostic Procedures
• Therapeutic Procedures
Therapeutic Nuclear Medicine Market, By Region

• Asia Pacific
• North America
• Europe
• South America
• Middle East & Africa
Key players operating in Therapeutic Nuclear Medicine Market

• Cardinal Health
• GE Healthcare
• Curium
• Lantheus Medical Imaging
• Bayer AG
• Bracco Imaging
• Eczacýbaþý-Monrol Nuclear Products (Turkey)
• Nordion (Canada)
• Advanced Accelerator Applications (France)
• NTP Radioisotopes (South Africa)
• JSC Isotope (Russia)
• NorthStar Medical Radioisotopes (US)
• Eckert & Ziegler (Germany)
• Jubilant DraxImage (Canada)
• PharmaLogic (US)
• Institute of Isotopes Co., Ltd. (Hungary)
• Sinotau Pharmaceuticals (China)
• Isotopia Molecular Imaging Limited (Israel)
• SHINE Medical Technologies (US)
• Global Medical Solutions (US)

For More Information Visit @:https://www.maximizemarketresearch.com/market-report/therapeutic-nu...

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:          

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research: 

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.